Steward Health Care to Sell Wadley Regional Medical Center in Texarkana, Texas to CHRISTUS Health
Steward Health Care to Sell Wadley Regional Medical Center in Texarkana, Texas to CHRISTUS Health
Steward Health affirmed today that it has entered into a definitive agreement to sell Wadley Regional Medical Center in Texarkana, Texas to CHRISTUS Health, an international, not-for-profit Catholic health system; this was approved by the court today.
CHRISTUS Health had been designated as the stalking horse bidder during auction process. The transaction remains subject to satisfaction of closing conditions, including receipt of necessary regulatory approvals.
“We are pleased, through this transaction, to have ensured continuity of care for our patients and the communities we serve,” said John Castellano, Steward’s Chief Restructuring Officer. “We are also deeply appreciative of our dedicated employees who have continued to provide excellent patient care during this time of transition.”
Steward is represented by Weil, Gotshal & Manges LLP (Restructuring Counsel), McDermott Will & Emery LLP (Regulatory Counsel), Cain Brothers, a division of KeyBanc Capital Markets Inc. (Healthcare Investment Banker), Leerink Partners LLC (Healthcare Investment Banker), and AlixPartners, LLP (Financial Advisor).
Additional information is available at www.steward.org
Media:
Josephine Martin
josephine.martin@steward.org
View source version on businesswire.com: https://www.businesswire.com/news/home/20240924530696/en/
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks